Previous studies have investigated the expression and biological effect of RBFOX2 in some tumors, such as nasopharyngeal carcinoma (Luo et al., 2021), endometrial cancer (Zhang et al., 2022) and ovarian cancer (Gordon et al., 2019). This evidence concerns the gene RBFOX2 and ovarian cancer.